Supplementary Figures Fig. 1 Transcript levels of Tissue Factor, PAR-1 and PAR-2 Expression if TF, PAR-1 and PAR-2 was analyzed in unstimulated HUVECs,

Slides:



Advertisements
Similar presentations
Supplementary Materials and Methods Real-time RT-PCR Genomic DNA was isolated from washed cell pellets of eight biliary tract cancer cell lines (SNU-245,
Advertisements

How do you identify and clone a gene of interest? Shotgun approach? Is there a better way?
【 Supplement methods 】 Real-Time Reverse Transcription-PCR Total RNA was isolated from HRGEc using the RNeasy® Mini Kit. cDNA was synthesized using Super-Script®
Normal skin tissue Supplementary Fig 1A KLF4 has a tumor suppressive function in human skin cancer. Skin cancer tissues were deparaffinized and IHC was.
Products > SKNAS Transfection Reagent (Neuroblastoma Cells) Altogen Biosystems offers the SKNAS Transfection Reagent among a host of 100+ cell line specific.
Altogen Biosystems offers the Transfection Reagent for PANC-1 Cells Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection.
Products > B16-F10 Transfection Reagent (Mouse Melanoma Cells) Altogen Biosystems offers the B16-F10 Transfection Reagent among a host of 100+ cell line.
Products > 293T/17 Transfection Reagent (Embryonic Kidney Cells, CRL-11268) Altogen Biosystems offers the 293T/17 Transfection Reagent among a host of.
Altogen Biosystems offers the J774A Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. The J774A Transfection Reagent.
Products > Transfection Reagent for BMS/BMS2 Cells (Bone Marrow Cells) Altogen Biosystems offers the BMS2 Transfection Reagent among a host of 100+ cell.
Fig. S1 Beclin1, ATG3 and LC3B mRNA -real-time quantitative PCR HCT-116 HT-29.
Products > VERO Transfection Reagent (Monkey Kidney Cells) Altogen Biosystems offers the VERO Cell Transfection Reagent among a host of 100+ cell line.
Products > U87 Transfection Reagent (Glioblastoma Cells) Altogen Biosystems offers the U87 Transfection Reagent among a host of 100+ cell line specific.
Products > PC-3 Transfection Reagent (Prostate Cancer Cells) Altogen Biosystems offers the PC-3 Transfection Reagent among a host of 100+ cell line specific.
Altogen Biosystems offers the 786-O Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. 786-O Transfection Reagent.
Products > MCF-7 Transfection Reagent (Breast Cancer, HTB-22) Altogen Biosystems offers the MCF-7 Transfection Reagent among a host of 100+ cell line specific.
Products > 3T3-L1 Transfection Reagent (Embryonic Fibroblast Cells, CL-173) Altogen Biosystems offers the 3T3-L1 Transfection Reagent among a host of 100+
Products > HUVEC Transfection Reagent (Human Umbilical Vein Endothelial Cells) Altogen Biosystems offers the HUVEC Transfection Reagent among a host of.
Products > HEK-293 Transfection Reagent (Epithelial Kidney Cells) Altogen Biosystems offers the HEK-293 Transfection Reagent among a host of 100+ cell.
Products > AGS Transfection Reagent (Gastric Adenocarcinoma, CRL1739) Altogen Biosystems offers the AGS Transfection Reagent among a host of 100+ cell.
Products > MG-63 Transfection Reagent (Osteosarcoma, CRL-1427) Altogen Biosystems offers the MG-63 Transfection Reagent among a host of 100+ cell line.
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > bEnd-3 Transfection Reagent (Brain Endothelioma)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > DI-TNC1 Transfection Reagent (Rat Brain Astrocytes)
Products > NCI-H1299 Transfection Reagent (Lung Adenocarcinoma)
Products > HT-1080 Transfection Reagent (Fibrosarcoma Cells)
Products > DLD-1 Transfection Reagent (Colon Cancer, CCL-221)
Products > CHO Transfection Reagent (Chinese Hamster Ovary Cells)
Products > SK-MEL-28 Transfection Reagent (Melanoma Cells, HTB72)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > Fibroblast Transfection Reagent (Fibroblast Cells)
Products > NIH3T3 Transfection Reagent (Swiss Mouse Fibroblasts)
Products > HUH-7 Transfection Reagent (Liver Cancer Cells)
Products > 293 Transfection Reagent (Emb Kidney, CRL-1573)
Products > C2C12 Transfection Reagent (Mouse Myoblast Cells)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > HCN-1A Transfection Reagent (Brain Neuronal Cells)
Products > SK-N-MC Transfection Reagent (Neuroblastoma Cells)
Products > Keratinocyte Transfection Reagent (Keratinocytes)
Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction  James.
Matrix-Degrading Metalloproteinases in Photoaging
Suppression of miR135b Increases the Proliferative Potential of Normal Human Keratinocytes  Hye-Ryung Choi, Kyung-Mi Nam, Sung-Jun Park, Dong-Seok Kim,
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Products > HCAEC Transfection Reagent (Coronary Artery Endothelial)
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > KB Transfection Reagent (Mouth Epidermal Carcinoma)
Smooth and textured silicone surfaces of modified gel mammary prostheses cause a different impact on fibroproliferative properties of dermal fibroblasts 
Products > MEF Transfection Reagent (Mouse Fibroblast Cells)
Products > Hep-3B Transfection Reagent (Hepatocellular Carcinoma)
Products > HepG2 Transfection Reagent (Hepatocellular Carcinoma)
Volume 120, Issue 1, Pages (January 2001)
Products > Hepa 1-6 Transfection Reagent (Hepatoma Cells)
Suppression of miR135b Increases the Proliferative Potential of Normal Human Keratinocytes  Hye-Ryung Choi, Kyung-Mi Nam, Sung-Jun Park, Dong-Seok Kim,
Development of comprehensive functional genomic screens to identify novel mediators of osteoarthritis  S. Daouti, M.S., B. Latario, M.S., S. Nagulapalli,
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion by John D. Belcher, Paul H. Marker,
Novel Functions of Intracellular IL-1ra in Human Dermal Fibroblasts: Implications in the Pathogenesis of Fibrosis  Siva Kanangat, Arnold E. Postlethwaite,
Products > NCI-H460 Transfection Reagent (Lung Carcinoma, HTB177)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > NCI-H23 Transfection Reagent (Lung Adenocarcinoma)
Products > HCT-116 Transfection Reagent (Colon Carcinoma)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Products > NCI-H292 Transfection Reagent (Lung Carcinoma, CRL1848)
Products > H9c2 Transfection Reagent (Embryonic Myocardium)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
Products > CLBPEC Transfection Reagent (Neuroblastoma Cells)
Identification of Skn-1n, a Splice Variant Induced by High Calcium Concentration and Specifically Expressed in Normal Human Keratinocytes  Koji Nakajima,
Tumor MMP-1 functionally regulates the permeability of endothelial cell barriers and contributes to HEp3-hi/diss transendothelial migration. Tumor MMP-1.
Presentation transcript:

Supplementary Figures Fig. 1 Transcript levels of Tissue Factor, PAR-1 and PAR-2 Expression if TF, PAR-1 and PAR-2 was analyzed in unstimulated HUVECs, in HUVECs after transfection with pEGFP, after stimulation with IL-1 beta (50 ng/ml) and in J82 cells. After transfection cells were incubated for 3 hours in serum free medium or stimulated without IL-1 beta. As a control untransfected, unstimulated cells were used. mRNA levels were quantified by TaqMan RT-PCR (n=2). Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. 1 µg of total RNA was reverse transcribed with Omniscript Reverse Transcriptase (Omniscript RT Kit, Qiagen, Hilden, Germany). Quantitative PCR of 150 ng cDNA was performed in a final volume of 25 µl. The PCR mixture contained 1x TaqMan Universal PCR Master Mix, 900 nmol/l of each primer and 250 nmol/l probe corresponding to 1x Assay-on-Demand (Applied Biosystems, Darmstadt, Germany). Assay-on-Demand containing primers and 6-carboxy-fluorescein (FAM)-labeled probes for PAR1 (Hs _m1), PAR2 (Hs _m1), TF (Hs _m1) and GAPDH (Hs _m1 ) were purchased from Applied Biosystems. The PCR protocol included 2 minutes at 50°C and 10 minutes at 95°C for enzyme activation, then 40 cycles of denaturation at 95°C for 15 seconds and annealing/extension at 60°C for 1 minute. Real-time fluorescence detection was performed and analyzed with the ABI PRISM 7700 Sequence Detector (Applied Biosystems). The threshold was set at 0.05 units of normalized fluorescence; the threshold cycle Ct was measured for each well. For normalization the Ct value of GAPDH was substracted from the test Ct value and the relative expression levels compared to IL-1 beta-stimulated HUVEC were calculated using the comparative Ct method (Livak KJ, Schmittgen DT. Analysis of relative gene expression data using real time quantitative PCR and the 2´(-  Ct) method. Methods 2001;25:402-8) HUVECHUVEC pEGFPJ82HUVEC+IL-1beta relative mRNA level TF PAR1 PAR2

HUVECHUVEC pEGFP FXa generation [mOD] HUVECHUVEC pEGFP Mean fl. A B Fig. 2 Transfection does not significantly enhances TF surface expression and TF activity HUVEC were transfected with vector control (pEGFP) using Effectene as described in the methods section (n=5). Twenty-four hours after transfection cells were seeded at a concentration of 10 5 cells/ml on 96 and 6 well plate and incubated for another 24 hours. Then cells were harvested for TF surface expression and activity. TF surface expression was analyzed by flow cytometry (A). TF activity was measured using a FXa generation assay as described in supplementary Tab. 2 (B)

Fig. 3 Similar increases in TF surface expression and TF activity after transfection with pEGFP-TF and pEGFP-TF  cyt. HUVEC were transfected with the TF contructs pEGFP-TF and pEGFP-TF  cyt or vector control (pEGFP). Twenty-four hours after transfection cells were seeded at a concentration of 10 5 cells/ml on 96 and 6 well plate and incubated for another 24 hours. Then cells were harvested for TF surface expression and activity. TF surface expression was analyzed by flow cytometry (A). TF activity was measured using a FXa generation assay as described in supplementary Tab. 2 (B) HUVEC pEGFP HUVEC pEGFP-TF HUVEC pEGFP-TF  cyt FXa generation [mOD] HUVEC pEGFP HUVEC pEGFP-TF HUVEC pEGFP-TF  cyt Mean fl. A B